| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2017-03-23 03:53:14 UTC |
|---|
| Update Date | 2022-09-22 17:44:12 UTC |
|---|
| HMDB ID | HMDB0062544 |
|---|
| Secondary Accession Numbers | - HMDB0000386
- HMDB00386
- HMDB0062611
- HMDB62544
- HMDB62611
|
|---|
| Metabolite Identification |
|---|
| Common Name | 16alpha-Hydroxy DHEA 3-sulfate |
|---|
| Description | 16alpha-Hydroxy DHEA 3-sulfate (16α-OH-DHEAS), also known as 3beta,16alpha-Dihydroxyandrostenone sulfate, belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 16alpha-Hydroxy DHEA 3-sulfate originates mainly from the fetus and is a precursor for placental estriol biosynthesis (PMID: 24717977 ). 16alpha-Hydroxy DHEA 3-sulfate is a normal human metabolite identified in the placenta and breast milk of pregnant women. The size of the neonate's adrenal glands is in direct relation to the levels of 16alpha-Hydroxy DHEA 3-sulfate in pregnancy (PMID: 2963083 , 2974194 , 6216072 , 6220027 , 6220952 , 6445373 ). |
|---|
| Structure | [H][C@@]12C[C@@H](O)C(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)OS(O)(=O)=O InChI=1S/C19H28O6S/c1-18-7-5-12(25-26(22,23)24)9-11(18)3-4-13-14(18)6-8-19(2)15(13)10-16(20)17(19)21/h3,12-16,20H,4-10H2,1-2H3,(H,22,23,24)/t12-,13+,14-,15-,16+,18-,19-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 16a-Hydroxydehydroepiandrosterone 3-sulfate | Generator | | 16a-Hydroxydehydroepiandrosterone 3-sulfuric acid | Generator | | 16a-Hydroxydehydroepiandrosterone 3-sulphate | Generator | | 16a-Hydroxydehydroepiandrosterone 3-sulphuric acid | Generator | | 16alpha-Hydroxydehydroepiandrosterone 3-sulfuric acid | Generator | | 16alpha-Hydroxydehydroepiandrosterone 3-sulphate | Generator | | 16alpha-Hydroxydehydroepiandrosterone 3-sulphuric acid | Generator | | 16α-Hydroxydehydroepiandrosterone 3-sulfate | Generator | | 16α-hydroxydehydroepiandrosterone 3-sulfuric acid | Generator | | 16α-Hydroxydehydroepiandrosterone 3-sulphate | Generator | | 16α-hydroxydehydroepiandrosterone 3-sulphuric acid | Generator | | (3b)-16a-Hydroxy-17-oxoandrost-5-en-3-yl sulfate | HMDB, Generator | | (3b)-16a-Hydroxy-17-oxoandrost-5-en-3-yl sulfuric acid | HMDB, Generator | | (3b)-16a-Hydroxy-17-oxoandrost-5-en-3-yl sulphate | HMDB, Generator | | (3b)-16a-Hydroxy-17-oxoandrost-5-en-3-yl sulphuric acid | HMDB, Generator | | (3b,16a)-16-Hydroxy-17-oxoandrost-5-en-3-yl sulfate | HMDB, Generator | | (3b,16a)-16-Hydroxy-17-oxoandrost-5-en-3-yl sulfuric acid | HMDB, Generator | | (3b,16a)-16-Hydroxy-17-oxoandrost-5-en-3-yl sulphate | HMDB, Generator | | (3b,16a)-16-Hydroxy-17-oxoandrost-5-en-3-yl sulphuric acid | HMDB, Generator | | (3beta)-16alpha-Hydroxy-17-oxoandrost-5-en-3-yl sulfate | HMDB, ChEBI | | (3beta)-16alpha-Hydroxy-17-oxoandrost-5-en-3-yl sulfuric acid | HMDB, Generator | | (3beta)-16alpha-Hydroxy-17-oxoandrost-5-en-3-yl sulphate | HMDB, Generator | | (3beta)-16alpha-Hydroxy-17-oxoandrost-5-en-3-yl sulphuric acid | HMDB, Generator | | (3beta,16alpha)-16-Hydroxy-17-oxoandrost-5-en-3-yl sulfate | HMDB, ChEBI | | (3beta,16alpha)-16-Hydroxy-17-oxoandrost-5-en-3-yl sulfuric acid | HMDB, Generator | | (3beta,16alpha)-16-Hydroxy-17-oxoandrost-5-en-3-yl sulphate | HMDB, Generator | | (3beta,16alpha)-16-Hydroxy-17-oxoandrost-5-en-3-yl sulphuric acid | HMDB, Generator | | (3β)-16α-Hydroxy-17-oxoandrost-5-en-3-yl sulfate | HMDB, Generator | | (3β)-16α-hydroxy-17-oxoandrost-5-en-3-yl sulfuric acid | HMDB, Generator | | (3β)-16α-Hydroxy-17-oxoandrost-5-en-3-yl sulphate | HMDB, Generator | | (3β)-16α-hydroxy-17-oxoandrost-5-en-3-yl sulphuric acid | HMDB, Generator | | (3β,16α)-16-Hydroxy-17-oxoandrost-5-en-3-yl sulfate | HMDB, Generator | | (3β,16α)-16-hydroxy-17-oxoandrost-5-en-3-yl sulfuric acid | HMDB, Generator | | (3β,16α)-16-Hydroxy-17-oxoandrost-5-en-3-yl sulphate | HMDB, Generator | | (3β,16α)-16-hydroxy-17-oxoandrost-5-en-3-yl sulphuric acid | HMDB, Generator | | 16a-Hydroxy-DHEA 3-sulfate | HMDB, Generator | | 16a-Hydroxy-DHEA 3-sulfuric acid | HMDB, Generator | | 16a-Hydroxy-DHEA 3-sulphate | HMDB, Generator | | 16a-Hydroxy-DHEA 3-sulphuric acid | HMDB, Generator | | 16alpha-Hydroxy-DHEA 3-sulfate | HMDB, ChEBI | | 16alpha-Hydroxy-DHEA 3-sulfuric acid | HMDB, Generator | | 16alpha-Hydroxy-DHEA 3-sulphate | HMDB, Generator | | 16alpha-Hydroxy-DHEA 3-sulphuric acid | HMDB, Generator | | 16α-Hydroxy-DHEA 3-sulfate | HMDB, Generator | | 16α-hydroxy-DHEA 3-sulfuric acid | HMDB, Generator | | 16α-Hydroxy-DHEA 3-sulphate | HMDB, Generator | | 16α-hydroxy-DHEA 3-sulphuric acid | HMDB, Generator | | 3b-Sulfooxy-16a-hydroxyandrost-5-en-17-one | HMDB, Generator | | 3b-Sulphooxy-16a-hydroxyandrost-5-en-17-one | HMDB, Generator | | 3beta-Sulfooxy-16alpha-hydroxyandrost-5-en-17-one | HMDB, ChEBI | | 3beta-Sulphooxy-16alpha-hydroxyandrost-5-en-17-one | HMDB, Generator | | 3β-Sulfooxy-16α-hydroxyandrost-5-en-17-one | HMDB, Generator | | 3β-sulphooxy-16α-hydroxyandrost-5-en-17-one | HMDB, Generator | | (3beta,16alpha)-16-Hydroxy-3-(sulfooxy)androst-5-en-17-one | HMDB | | (3β,16α)-16-Hydroxy-3-(sulfooxy)androst-5-en-17-one | HMDB | | 16alpha-Hydroxy DHEA 3-sulfate | HMDB | | 16alpha-Hydroxy DHEA 3-sulphate | HMDB | | 16alpha-Hydroxy DHEA sulfate | HMDB | | 16alpha-Hydroxy DHEA sulphate | HMDB | | 16alpha-Hydroxy-DHEA sulfate | HMDB | | 16alpha-Hydroxy-DHEA sulphate | HMDB | | 16alpha-Hydroxydehydroepiandrosterone 3-sulfate | HMDB | | 16alpha-Hydroxydehydroisoandrosterone sulfate | HMDB | | 16alpha-Hydroxydehydroisoandrosterone sulphate | HMDB | | 16alpha-OH DHEAS | HMDB | | 16alpha-OH-DHEA-3S | HMDB | | 16alpha-OH-DHEA-S | HMDB | | 16alpha-OH-DHEAS | HMDB | | 16α-Hydroxy DHEA 3-sulfate | HMDB | | 16α-Hydroxy DHEA 3-sulphate | HMDB | | 16α-Hydroxy DHEA sulfate | HMDB | | 16α-Hydroxy DHEA sulphate | HMDB | | 16α-Hydroxy-DHEA sulfate | HMDB | | 16α-Hydroxy-DHEA sulphate | HMDB | | 16α-Hydroxydehydroisoandrosterone sulfate | HMDB | | 16α-Hydroxydehydroisoandrosterone sulphate | HMDB | | 16α-OH DHEAS | HMDB | | 16α-OH-DHEA-3S | HMDB | | 16α-OH-DHEA-S | HMDB | | 16α-OH-DHEAS | HMDB | | 3beta,16alpha-Dihydroxy-5-androsten-17-one 3-sulfate | HMDB | | 3beta,16alpha-Dihydroxy-5-androsten-17-one 3-sulphate | HMDB | | 3β,16α-Dihydroxy-5-androsten-17-one 3-sulfate | HMDB | | 3β,16α-Dihydroxy-5-androsten-17-one 3-sulphate | HMDB | | (3beta,16alpha)-3,16-Dihydroxyandrost-5-en-17-one sulfate | HMDB | | (3beta,16alpha)-3,16-Dihydroxyandrost-5-en-17-one sulphate | HMDB | | (3β,16α)-3,16-Dihydroxyandrost-5-en-17-one sulfate | HMDB | | (3β,16α)-3,16-Dihydroxyandrost-5-en-17-one sulphate | HMDB | | 3b,16a-Dihydroxyandrostenone sulfate | HMDB | | 3b,16a-Dihydroxyandrostenone sulphate | HMDB | | 3beta,16alpha-Dihydroxyandrost-5-en-17-one sulfate | HMDB | | 3beta,16alpha-Dihydroxyandrost-5-en-17-one sulphate | HMDB | | 3beta,16alpha-Dihydroxyandrostenone sulfate | HMDB | | 3beta,16alpha-Dihydroxyandrostenone sulphate | HMDB | | 3β,16α-Dihydroxyandrost-5-en-17-one sulfate | HMDB | | 3β,16α-Dihydroxyandrost-5-en-17-one sulphate | HMDB | | 3β,16α-Dihydroxyandrostenone sulfate | HMDB | | 3β,16α-Dihydroxyandrostenone sulphate | HMDB |
|
|---|
| Chemical Formula | C19H28O6S |
|---|
| Average Molecular Weight | 384.49 |
|---|
| Monoisotopic Molecular Weight | 384.160659796 |
|---|
| IUPAC Name | [(1S,2R,5S,10R,11S,13R,15S)-13-hydroxy-2,15-dimethyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl]oxidanesulfonic acid |
|---|
| Traditional Name | [(1S,2R,5S,10R,11S,13R,15S)-13-hydroxy-2,15-dimethyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl]oxidanesulfonic acid |
|---|
| CAS Registry Number | 4873-65-8 |
|---|
| SMILES | [H][C@@]12C[C@@H](O)C(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)OS(O)(=O)=O |
|---|
| InChI Identifier | InChI=1S/C19H28O6S/c1-18-7-5-12(25-26(22,23)24)9-11(18)3-4-13-14(18)6-8-19(2)15(13)10-16(20)17(19)21/h3,12-16,20H,4-10H2,1-2H3,(H,22,23,24)/t12-,13+,14-,15-,16+,18-,19-/m0/s1 |
|---|
| InChI Key | ALBNSVAJDFJRKQ-DNKQKWOHSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Sulfated steroids |
|---|
| Direct Parent | Sulfated steroids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Sulfated steroid skeleton
- Androstane-skeleton
- Hydroxysteroid
- 17-oxosteroid
- Oxosteroid
- 16-alpha-hydroxysteroid
- 16-hydroxysteroid
- Delta-5-steroid
- Sulfate-ester
- Sulfuric acid monoester
- Alkyl sulfate
- Sulfuric acid ester
- Organic sulfuric acid or derivatives
- Cyclic alcohol
- Secondary alcohol
- Ketone
- Organic oxide
- Organic oxygen compound
- Organooxygen compound
- Alcohol
- Carbonyl group
- Hydrocarbon derivative
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.078 g/l | ALOGPS | | LogP | 1.22 | ALOGPS |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.33 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 14.7156 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.63 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2640.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 283.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 190.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 180.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 307.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 591.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 687.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 86.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1142.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 454.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1587.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 344.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 443.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 322.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 299.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 75.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 16alpha-Hydroxy DHEA 3-sulfate,1TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC[C@@]43C)[C@@H]1C[C@@H](O[Si](C)(C)C)C2=O | 3236.3 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,1TMS,isomer #2 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1C[C@@H](O)C2=O | 3246.4 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,1TMS,isomer #3 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC[C@@]43C)[C@@H]1CC(O)=C2O[Si](C)(C)C | 3216.3 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1C[C@@H](O[Si](C)(C)C)C2=O | 3287.2 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1C[C@@H](O[Si](C)(C)C)C2=O | 3303.0 | Standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1C[C@@H](O[Si](C)(C)C)C2=O | 3997.1 | Standard polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TMS,isomer #2 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC[C@@]43C)[C@@H]1CC(O[Si](C)(C)C)=C2O[Si](C)(C)C | 3245.3 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TMS,isomer #2 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC[C@@]43C)[C@@H]1CC(O[Si](C)(C)C)=C2O[Si](C)(C)C | 3202.9 | Standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TMS,isomer #2 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC[C@@]43C)[C@@H]1CC(O[Si](C)(C)C)=C2O[Si](C)(C)C | 4059.5 | Standard polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TMS,isomer #3 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC(O)=C2O[Si](C)(C)C | 3232.9 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TMS,isomer #3 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC(O)=C2O[Si](C)(C)C | 3207.2 | Standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TMS,isomer #3 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC(O)=C2O[Si](C)(C)C | 3959.1 | Standard polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,3TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC(O[Si](C)(C)C)=C2O[Si](C)(C)C | 3265.8 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,3TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC(O[Si](C)(C)C)=C2O[Si](C)(C)C | 3399.2 | Standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,3TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC(O[Si](C)(C)C)=C2O[Si](C)(C)C | 3901.5 | Standard polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@@H]1C[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O)CC[C@]4(C)[C@H]3CC[C@]2(C)C1=O | 3498.5 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OS(=O)(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4C[C@@H](O)C(=O)[C@@]4(C)CC[C@@H]32)C1 | 3485.3 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=C(O)C[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C | 3472.3 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@@H]1C[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]2(C)C1=O | 3745.4 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@@H]1C[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]2(C)C1=O | 3908.6 | Standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@@H]1C[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]2(C)C1=O | 4151.0 | Standard polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=C(O[Si](C)(C)C(C)(C)C)[C@@]2(C)CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC[C@@]43C)[C@@H]2C1 | 3742.1 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=C(O[Si](C)(C)C(C)(C)C)[C@@]2(C)CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC[C@@]43C)[C@@H]2C1 | 3774.5 | Standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=C(O[Si](C)(C)C(C)(C)C)[C@@]2(C)CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC[C@@]43C)[C@@H]2C1 | 4211.8 | Standard polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=C(O)C[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3679.8 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=C(O)C[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3787.2 | Standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=C(O)C[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 4128.1 | Standard polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=C(O[Si](C)(C)C(C)(C)C)[C@@]2(C)CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C(C)(C)C)CC[C@@]43C)[C@@H]2C1 | 3907.0 | Semi standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=C(O[Si](C)(C)C(C)(C)C)[C@@]2(C)CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C(C)(C)C)CC[C@@]43C)[C@@H]2C1 | 4227.8 | Standard non polar | 33892256 | | 16alpha-Hydroxy DHEA 3-sulfate,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=C(O[Si](C)(C)C(C)(C)C)[C@@]2(C)CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C(C)(C)C)CC[C@@]43C)[C@@H]2C1 | 4083.0 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate GC-MS (Non-derivatized) - 70eV, Positive | splash10-0cdl-0049000000-273a75dc3d6141b9788c | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate GC-MS (1 TMS) - 70eV, Positive | splash10-0096-1049800000-47818e0e6c4513508f92 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate 10V, Positive-QTOF | splash10-000i-0049000000-ae4f8e4741067f9517ce | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate 20V, Positive-QTOF | splash10-000i-0091000000-5484c08bc6ae08337006 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate 40V, Positive-QTOF | splash10-0cdj-2690000000-0b46374982741b156bdc | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate 10V, Negative-QTOF | splash10-001i-0019000000-23a63b39a7b42e2be350 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate 20V, Negative-QTOF | splash10-0udr-0059000000-03cbbc461804a913280a | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate 40V, Negative-QTOF | splash10-0f80-6093000000-9277a26e795d1d7493dd | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate 10V, Positive-QTOF | splash10-000i-0019000000-8ae59fa662a1ec302469 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate 20V, Positive-QTOF | splash10-000i-0292000000-e74355bcadf5363f37a1 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate 40V, Positive-QTOF | splash10-052f-3941000000-8caacde77c9e4e47392a | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate 10V, Negative-QTOF | splash10-001i-0009000000-5c281ab6096b4ad82924 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate 20V, Negative-QTOF | splash10-001i-1009000000-7f5e5a2d241c356bfa10 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 16alpha-Hydroxy DHEA 3-sulfate 40V, Negative-QTOF | splash10-002b-5009000000-1642eed98c9ed3da713b | 2021-09-24 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-18 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Smith JL, Lewindon PJ, Hoskins AC, Pereira TN, Setchell KD, O'Connell NC, Shepherd RW, Ramm GA: Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis. Hepatology. 2004 Jun;39(6):1673-82. [PubMed:15185309 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Schweigmann H, Sanchez-Guijo A, Ugele B, Hartmann K, Hartmann MF, Bergmann M, Pfarrer C, Doring B, Wudy SA, Petzinger E, Geyer J, Grosser G: Transport of the placental estriol precursor 16alpha-hydroxy-dehydroepiandrosterone sulfate (16alpha-OH-DHEAS) by stably transfected OAT4-, SOAT-, and NTCP-HEK293 cells. J Steroid Biochem Mol Biol. 2014 Sep;143:259-65. doi: 10.1016/j.jsbmb.2014.03.013. Epub 2014 Apr 6. [PubMed:24717977 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
- Branchaud CL, Goodyer CG, Lipowski LS: Progesterone and estrogen production by placental monolayer cultures: effect of dehydroepiandrosterone and luteinizing hormone-releasing hormone. J Clin Endocrinol Metab. 1983 Apr;56(4):761-6. doi: 10.1210/jcem-56-4-761. [PubMed:6220027 ]
- Matsumura I, Hashino M, Maruyama S, Yanaihara T, Nakayama T: [Relation between size of fetal and neonatal adrenal glands and steroid levels in maternal and neonatal serum]. Nihon Sanka Fujinka Gakkai Zasshi. 1987 Dec;39(12):2125-32. [PubMed:2963083 ]
- Raju U, Levitz M, Jacobowitz G, Fleisher M, Bencsath FA, Field FH, Breed CN, Naganuma H, Bradlow HL: Quantification of the sulfates of 16 alpha-hydroxy androgens that are possible precursors of estriol-3-sulfate in human breast cyst fluid. Steroids. 1987 Oct-Dec;50(4-6):559-74. doi: 10.1016/0039-128x(87)90039-0. [PubMed:2974194 ]
- Nakayama T, Yanaihara T: Placental sulfatase deficiency. Biochemical and clinical aspects. Contrib Gynecol Obstet. 1982;9:145-56. [PubMed:6216072 ]
- Dibbelt L, Kuss E: Human placental steroid-sulfatase. Kinetics of the in-vitro hydrolysis of dehydroepiandrosterone 3-sulfate and of 16 alpha-hydroxydehydroepiandrosterone 3-sulfate. Hoppe Seylers Z Physiol Chem. 1983 Feb;364(2):187-91. [PubMed:6220952 ]
- Yamaji T, Ishibashi M, Katayama S, Kosaka K: Serum 16 beta-hydroxydehydroepiandrosterone sulfate in man. J Clin Endocrinol Metab. 1980 May;50(5):955-60. doi: 10.1210/jcem-50-5-955. [PubMed:6445373 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
|---|